Locate Chandler buprenorphine and suboxone doctors who specialize in the treatment of opioid addiction.
|
Steven Joseph Locnikar, D.O.
501 North Washington
Suite 103
Chandler, AZ 85225
Main Tel: (480) 219-0055
|
|
Steven Joseph Locnikar, D.O.
501 North Washington
Suite 103
Chandler, AZ 85225
Main Tel: (480) 831-9533
|
|
Dr. James Carl Barsz, M.D.
501 North Washington Street
Chandler, AZ 85225
Main Tel: (480) 899-3335
|
|
Michael Mahl, M.D.
Medical Arts Plaza
312 North Alma School Road, Suite 17
Chandler, AZ 85224
Main Tel: (480) 732-1900
|
|
Dr. Daniel Charles Mac Dougall, M.D.
PHOENICIAN MEDICAL CENTER
1343 N Alma School Rd # 125
Chandler, AZ 85224
Main Tel: (480) 776-2982
|
|
Dr. Harry Carl Watters, D.O.
604 West Warner Road
Chandler, AZ 85225
Main Tel: (480) 963-7900
|
|
Dr. Wladislaw G. Fedoriw, M.D.
2320 West Ray Road
Ste 1
Chandler, AZ 85224
Main Tel: (480) 659-2571
|
|
Amish S. Purohit, M.D.
Arizona Priority Care Plus
706 North McQueen Road, Suite 109
Gilbert, AZ 85233
Main Tel: (480) 800-6400
|
|
Mehmud Ahmed, M.D.
4055 West Chandler Boulevard
Suite 5
Chandler, AZ 85226
Main Tel: (480) 464-4431
|
|
Dr. Lauro Amezcua-Patino, M.D.
4055 West Chandler Boulevard
Suite 5
Chandler, AZ 85226
Main Tel: (480) 464-4431
|
|
Dr. Joshua Adam Levy, D.O.
81 West Guadalupe Road
Suite 111
Gilbert, AZ 85233
Main Tel: (480) 366-4490
|
Sublocade Now Available
Sublocade is a newly released medication alternative for treating opioid addiction. It is a product of Indivior, the pharmaceutical company responsible for Suboxone. Sublocade is a once monthly injection of time-released buprenorphine typically provided to patients who have been receiving buprenorphine for at least (7) days and who are stable on their medication. The injection Read More
Ohio Increases Buprenorphine Access
In 2017, Ohio increased its number of buprenorphine-approved prescribers by 266. This was the result of a $2.3 million dollar Federal grant that provided state-wide training to doctors, nurse practitioners, and physician assistants as reported by Cleveland.com. Historically, Ohio had numerous communities that were underserved with 19 counties having no buprenorphine providers at the beginning Read More
The Drug Treatment Act of 2000 permitted doctors who meet certain training qualifications to prescribe buprenorphine in the treatment of heroin addiction and other opioid addictions. Buprenorphine physicians became able to assist opioid addicted patients in an office setting bypassing the restrictions that typically apply to patients receiving methadone. This treatment method maximized patient convenience and accessibility thus increasing the number of people who could access medication-assisted treatment (MAT) for opioid addiction.
Sublocade is a newly released medication alternative for treating opioid addiction. It is a product of Indivior, the pharmaceutical company responsible for